Source:http://linkedlifedata.com/resource/pubmed/id/17053452
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2006-10-20
|
pubmed:abstractText |
Sickle cell disease and beta-thalassemia major are clinically significant hereditary anemias that elicit worldwide attention due to the frequency and severity of these disorders. Historically, most children who inherited these disorders died in the first decade of life. Recently, however, supportive care has extended lifespan through the fifth decade of life and beyond, with survival through early adulthood now indistinguishable from those unaffected by these disorders. As a result, chronic health impairments that significantly reduce the quality of life such as pulmonary hypertension and the consequences of transfusional iron overload have become principal challenges.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1065-6251
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
407-18
|
pubmed:meshHeading |
pubmed-meshheading:17053452-Anemia, Sickle Cell,
pubmed-meshheading:17053452-Arginine,
pubmed-meshheading:17053452-Child,
pubmed-meshheading:17053452-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:17053452-Humans,
pubmed-meshheading:17053452-Hypertension, Pulmonary,
pubmed-meshheading:17053452-Iron Chelating Agents,
pubmed-meshheading:17053452-Iron Overload,
pubmed-meshheading:17053452-Prognosis,
pubmed-meshheading:17053452-beta-Thalassemia
|
pubmed:year |
2006
|
pubmed:articleTitle |
Clinical hemoglobinopathies: iron, lungs and new blood.
|
pubmed:affiliation |
Children's Hospital & Research Center Oakland, Oakland, CA 94609, USA.
|
pubmed:publicationType |
Journal Article,
Review
|